Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy

Background: We assessed the use of serum concentrations of carbohydrate antigen (CA) 19–9 and carcinoembryonic antigen (CEA) measured during the preoperative diagnostic workup as prognostic factors for survival in patients with periampullary carcinoma. Methods: A retrospective review of patients dia...

Full description

Bibliographic Details
Main Authors: Sang Hun Park, Jun Ho Shin, Kyung Uk Jung, Sung Ryol Lee
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Asian Journal of Surgery
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1015958421000270
_version_ 1818573742061649920
author Sang Hun Park
Jun Ho Shin
Kyung Uk Jung
Sung Ryol Lee
author_facet Sang Hun Park
Jun Ho Shin
Kyung Uk Jung
Sung Ryol Lee
author_sort Sang Hun Park
collection DOAJ
description Background: We assessed the use of serum concentrations of carbohydrate antigen (CA) 19–9 and carcinoembryonic antigen (CEA) measured during the preoperative diagnostic workup as prognostic factors for survival in patients with periampullary carcinoma. Methods: A retrospective review of patients diagnosed with periampullary carcinoma who underwent radical surgery was conducted. Factors related to the survival of periampullary carcinoma patients, including CA 19–9 and CEA, were analyzed. Results: The mean age of the 112 patients included in the results was 66.41 ± 10.513 years. In the study, the percentage of patients with elevated serum CA 19–9 and CEA concentrations was 65.2% and 24.1%, respectively. CA 19–9 concentrations were correlated with the tumor stage, pre-operative jaundice, and lymphovascular invasion, but CEA concentrations were not. The median overall survival was longer for the normal serum CA 19-9 group than the group with increased CA 19–9 (56 months vs. 25 months, p = 0.003); however, there was no statistically significant difference between the normal serum CEA group and the group with increased CEA (43 months vs. 25 months, p = 0.077). Independent factors related to overall survival were sex, age, stage, presence of jaundice, lymphovascular invasion, perineural invasion, margin status, and elevated serum CA 19–9 concentrations. Conclusions: Periampullary carcinoma patients with elevated serum CA 19–9 concentrations at diagnosis are expected to have poor overall survival. CA 19–9 may be a useful marker for predicting prognosis in patients with periampullary carcinoma at the time of diagnosis.
first_indexed 2024-12-15T00:16:57Z
format Article
id doaj.art-b219847bb3c346498438586dbb9f6883
institution Directory Open Access Journal
issn 1015-9584
language English
last_indexed 2024-12-15T00:16:57Z
publishDate 2021-06-01
publisher Elsevier
record_format Article
series Asian Journal of Surgery
spelling doaj.art-b219847bb3c346498438586dbb9f68832022-12-21T22:42:26ZengElsevierAsian Journal of Surgery1015-95842021-06-01446829835Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomySang Hun Park0Jun Ho Shin1Kyung Uk Jung2Sung Ryol Lee3Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaCorresponding author. Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul, 03181, Republic of Korea.; Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaBackground: We assessed the use of serum concentrations of carbohydrate antigen (CA) 19–9 and carcinoembryonic antigen (CEA) measured during the preoperative diagnostic workup as prognostic factors for survival in patients with periampullary carcinoma. Methods: A retrospective review of patients diagnosed with periampullary carcinoma who underwent radical surgery was conducted. Factors related to the survival of periampullary carcinoma patients, including CA 19–9 and CEA, were analyzed. Results: The mean age of the 112 patients included in the results was 66.41 ± 10.513 years. In the study, the percentage of patients with elevated serum CA 19–9 and CEA concentrations was 65.2% and 24.1%, respectively. CA 19–9 concentrations were correlated with the tumor stage, pre-operative jaundice, and lymphovascular invasion, but CEA concentrations were not. The median overall survival was longer for the normal serum CA 19-9 group than the group with increased CA 19–9 (56 months vs. 25 months, p = 0.003); however, there was no statistically significant difference between the normal serum CEA group and the group with increased CEA (43 months vs. 25 months, p = 0.077). Independent factors related to overall survival were sex, age, stage, presence of jaundice, lymphovascular invasion, perineural invasion, margin status, and elevated serum CA 19–9 concentrations. Conclusions: Periampullary carcinoma patients with elevated serum CA 19–9 concentrations at diagnosis are expected to have poor overall survival. CA 19–9 may be a useful marker for predicting prognosis in patients with periampullary carcinoma at the time of diagnosis.http://www.sciencedirect.com/science/article/pii/S1015958421000270PancreaticoduodenectomyPrognosisSurvivalCA-19-9 antigenCarcinoembryonic antigen
spellingShingle Sang Hun Park
Jun Ho Shin
Kyung Uk Jung
Sung Ryol Lee
Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy
Asian Journal of Surgery
Pancreaticoduodenectomy
Prognosis
Survival
CA-19-9 antigen
Carcinoembryonic antigen
title Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy
title_full Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy
title_fullStr Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy
title_full_unstemmed Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy
title_short Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy
title_sort prognostic value of carcinoembryonic antigen and carbohydrate antigen 19 9 in periampullary cancer patients receiving pancreaticoduodenectomy
topic Pancreaticoduodenectomy
Prognosis
Survival
CA-19-9 antigen
Carcinoembryonic antigen
url http://www.sciencedirect.com/science/article/pii/S1015958421000270
work_keys_str_mv AT sanghunpark prognosticvalueofcarcinoembryonicantigenandcarbohydrateantigen199inperiampullarycancerpatientsreceivingpancreaticoduodenectomy
AT junhoshin prognosticvalueofcarcinoembryonicantigenandcarbohydrateantigen199inperiampullarycancerpatientsreceivingpancreaticoduodenectomy
AT kyungukjung prognosticvalueofcarcinoembryonicantigenandcarbohydrateantigen199inperiampullarycancerpatientsreceivingpancreaticoduodenectomy
AT sungryollee prognosticvalueofcarcinoembryonicantigenandcarbohydrateantigen199inperiampullarycancerpatientsreceivingpancreaticoduodenectomy